Cancers gynécologiques

RAINBO

Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials · p53abn - RED.

Open at Paris since : 31/10/2024
Target : Adult
Phase : Phase III

Trial description

To assess whether maintenance therapy with olaparib improves recurrence-free survival (RFS), as compared to observation after chemo-radiotherapy in patients with p53abn HREC.

Url of the trial

Main investigator

AUDREY BELLESOEUR

Médecin

Contact